Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab
Clinical trial NCT01250678 · UNKNOWN
Trial details
- NCT number
- NCT01250678
- Sponsor
- Cantonal Hospital of St. Gallen
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2011-01-01
- Primary completion
- 2014-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.